FPA-154

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameFPA-154
Drug Alias NameGITR costimulator (Five Prime Therapeutics/INHIBRx)anti-GITR antibody (Five Prime Therapeutics/INHIBRx)cmFPA-154INBRX-110FPA-154
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein agonistsImmunostimulantsT lymphocytes stimulants
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInhibrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFive Prime Therapeutics IncInhibrx Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A